CDK5 and liver cancer: Apigenin has also been reported as an indirect activator of the PDR via cyclin-dependent kinase 5 (Cdk5) in human HepG2 liver cancer cells, however, the ability of the flavonoid to interact directly with the PXR has been ruled out [160].